This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Urinary organ, other/unspecified
CD2_BENIGN_URINARY_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Urinary organ, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Urinary organ, other/unspecified
- Benign neoplasm of urinary organs
- Benign neoplasm of urinary organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 100 | 63 | 37 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 50.12 | 46.55 | 56.19 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 90
- Matched controls
- 898
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D30.9
ICD-10 Finland
Benign neoplasm: Urinary organ, unspecified
+∞
51.0
44
*
22388
ICD-8 Finland
Benign neoplasm of kidney and other urinary organs, Other specified sites
+∞
18.3
17
*
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
+∞
11.7
11
*
D30.7
ICD-10 Finland
Benign neoplasm: Other urinary organs
+∞
10.6
10
*
UKC02
NOMESCO Finland
Cystoscopy
5.5
8.6
27
65
22399
ICD-8 Finland
Benign neoplasm of kidney and other urinary organs, Unspecified site
+∞
8.5
8
*
115
Kela drug reimbursment
Breast cancer
+∞
7.4
7
*
130
Kela drug reimbursment
Malignant tumour
+∞
7.4
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.4
7
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
19.7
6.4
9
5
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
28.9
6.3
8
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
6.3
6
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
32
193
1.97
2.39
2.7
2.9
0.2
0.6
e6/l
1.15
24
140
29
178
1.89
2.03
2.2
2.1
2.5
2.9
mg/l
0.58
24
150
7
23
3.19
1.83
1.9
1.7
—
—
—
0
0
7
23
3.19
1.83
1.4
1.6
—
—
—
0
0
43
306
1.71
1.82
3.8
3.1
35.5
35.9
g/l
0.26
38
280
14
68
2.23
1.80
3.9
3.0
—
—
—
0
0
43
308
1.69
1.77
3.6
2.7
116.5
104.8
ug/l
0.17
38
290
11
49
2.40
1.70
1.4
1.7
—
—
—
0
0
9
38
2.50
1.50
14.3
5.1
23.9
25.7
mmol/l
—
9
38
18
104
1.89
1.49
3.2
2.0
0.8
0.8
mmol/l
0.03
18
96
34
239
1.64
1.46
3.7
2.9
—
—
—
0
0
6
23
2.71
1.39
1.5
2.5
—
—
—
0
0
5
17
3.04
1.37
3.8
1.3
—
—
—
0
0
19
115
1.81
1.37
2.7
2.8
2.8
1.2
e6/l
0.44
11
66
5
19
2.71
1.23
1.6
2.3
—
—
—
0
0
11
57
2.04
1.22
1.5
1.8
—
—
—
0
0
54
441
1.49
1.14
6.0
4.0
7.3
6.7
mmol/l
1.05
48
407
17
106
1.73
1.11
2.8
3.1
117.3
4.6
e6/l
—
8
57
14
83
1.80
1.08
7.1
4.3
1.1
1.0
mmol/l
0.28
14
69
9
49
1.92
1.02
6.2
2.2
1.2
1.2
mmol/l
—
9
38
41
323
1.46
1.01
10.3
4.3
1.2
1.2
mmol/l
0.02
36
288
39
310
1.42
0.90
3.8
3.6
36.5
44.1
ng/l
0.18
24
207
8
43
1.93
0.90
1.3
1.4
—
—
—
0
0
8
45
1.84
0.86
6.9
2.2
5.4
5.2
kpa
—
8
38
65
578
1.36
0.70
9.2
5.2
82.9
75.4
u/l
0.44
60
528
22
164
1.44
0.70
1.5
1.3
0.5
2.3
u/ml
—
6
47
48
409
1.33
0.69
8.1
7.0
3.7
4.2
e9/l
0.65
38
354
25
192
1.40
0.68
7.0
3.8
0.0
0.0
estimate
0.00
14
61
45
383
1.32
0.64
6.4
3.7
10.3
11.6
umol/l
0.41
39
356
40
336
1.32
0.62
2.4
1.9
92.8
96.2
pmol/l
0.19
22
155
38
317
1.32
0.62
3.7
3.7
—
—
—
0
0
42
356
1.31
0.61
13.3
5.0
1.2
1.2
mmol/l
0.39
30
313
42
358
1.30
0.58
5.7
3.7
0.0
0.0
estimate
0.00
14
66
20
154
1.37
0.54
2.9
1.7
1217.5
1135.4
nmol/l
0.19
13
118
42
365
1.26
0.48
7.1
5.0
0.0
0.0
estimate
0.00
14
62
42
370
1.23
0.42
5.6
3.8
0.0
0.0
estimate
0.00
14
63
33
284
1.24
0.40
6.5
3.7
—
—
—
0
0
67
716
0.81
0.40
4.3
4.4
1.4
1.3
mmol/l
0.70
61
643
70
743
0.81
0.38
4.8
4.8
1.4
1.5
mmol/l
1.41
65
681
20
163
1.28
0.38
2.4
1.9
—
—
—
0
0
71
750
0.82
0.35
4.7
4.9
4.8
4.7
mmol/l
0.40
66
689
13
103
1.30
0.30
1.8
1.6
—
—
—
0
0
14
114
1.27
0.27
1.6
1.3
—
—
—
0
0
9
74
1.24
0.26
1.3
1.5
—
—
—
0
0
62
584
1.16
0.26
5.7
4.2
12.7
12.2
mm/h
0.13
57
534
5
38
1.33
0.23
3.2
1.4
—
—
—
0
0
74
769
0.85
0.22
5.3
5.5
2.9
2.7
mmol/l
0.62
67
705
21
183
1.19
0.22
1.7
1.6
22.3
20.3
nmol/l
0.14
15
155
5
41
1.23
0.22
23.6
5.8
0.9
1.7
%
—
5
41
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1.8
—
0
5
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
62
589
1.14
0.21
6.0
4.2
14.8
14.8
pmol/l
0.01
53
538
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
78
754
1.16
0.19
18.8
11.7
23.5
20.3
mg/l
0.38
67
585
73
703
1.14
0.19
16.5
10.9
78.5
78.3
ml/min/173m2
0.03
63
559
49
516
0.90
0.16
4.1
2.8
47.1
44.1
u/l
0.10
41
477
73
749
0.91
0.12
5.8
4.8
6.1
6.0
mmol/l
0.37
66
683
7
65
1.08
0.08
2.0
1.8
—
—
—
0
0
81
796
1.09
0.08
21.0
14.0
83.0
76.3
umol/l
0.64
81
796
8
74
1.09
0.08
1.4
1.6
—
—
—
0
0
72
705
1.08
0.07
6.8
5.1
1.7
1.9
mu/l
0.49
63
637
15
138
1.10
0.07
1.2
1.3
61.5
10.9
u/ml
—
5
51
9
101
0.88
0.06
6.4
7.7
—
—
—
0
0
43
437
0.97
0.01
2.8
2.6
—
—
—
0
0
72
723
0.99
0.00
7.3
6.3
40.7
40.6
mmol/mol
0.01
67
671
15
146
1.03
0.00
5.6
3.5
20.5
25.2
%
—
7
57
12
116
1.04
0.00
1.9
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
17.8
—
0
5
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_URINARY_NOS_EXALLC – Benign neoplasm: Urinary organ, other/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).